Carl-Johan Zetterberg Boudrie appointed new CFO and member of Vimian’s management team

Regulatory press release
Jul 14 2022

Carl-Johan Zetterberg Boudrie appointed new CFO and member of Vimian’s management team

Vimian Group appoints Carl-Johan Zetterberg Boudrie as new Chief Financial Officer (CFO) and intends to continue to build out its finance organisation to support Vimian’s growth journey. Carl-Johan assumes the position as CFO and member of the Vimian Group management team, and succeeds Henrik Halvorsen who has decided to focus on his role as CFO of Vimian’s Specialty Pharma segment Nextmune.

Carl-Johan Zetterberg Boudrie has extensive experience as CFO in publicly traded companies as well as from senior leadership positions within business development, M&A and management consulting at Beijer Electronics, SEB and Capgemini. The past six years, Carl-Johan held positions as CFO and subsequently CEO of the technology company Doro AB (publ) listed on Nasdaq Stockholm. Most recently, he was CEO of Careium AB (publ), a spin-off from Doro AB.

Carl-Johan Zetterberg Boudrie succeeds Henrik Halvorsen who has held dual positions as CFO of Vimian and CFO of Vimian’s Specialty Pharma segment Nextmune, and who now decided to focus solely on his position at Nextmune.

“I am pleased to welcome Carl-Johan Zetterberg Boudrie as our new CFO. He has a strong background in finance from publicly listed companies and in addition, he brings a wealth of experience in strategy, business development and acquisition growth. He is an experienced and appreciated leader and I am delighted to have him onboard as we continue to build out our finance organisation to support our growth journey. At the same time, I would like to sincerely thank Henrik Halvorsen for his efforts on Vimian level and I respect his decision to focus on Nextmune”, says Fredrik Ullman CEO of Vimian Group.

“I am excited to join the fast-growing and global Vimian Group and become part of a dynamic and entrepreneurial organisation with a great vision to improve animal health”, says Carl-Johan Zetterberg Boudrie, incoming CFO of Vimian Group.

“It has been a privilege to lead the finance team throughout the formation of Vimian and the company’s public listing in June last year. As both Vimian and Nextmune have grown rapidly over the past year, I have decided to focus on my role at Nextmune and look forward to continuing our exciting journey in the global animal health market”, says Henrik Halvorsen, CFO of Vimian Group.

Henrik Halvorsen will remain as Vimian’s CFO until Carl-Johan Zetterberg Boudrie has assumed his position. Carl-Johan will assume the position as CFO of Vimian as soon as a successor has been appointed for his current position.

About Vimian

Vimian is a global, fast-growing group of innovation-driven companies with a shared passion for making a positive impact through improving animal health. Together, we put science, technology and our customers’ needs at the centre of everything we do to deliver effective solutions to veterinary professionals, labs and pet parents around the world. We bring together pioneering and entrepreneurial businesses in animal health, with an aim to create a uniquely diversified proposition of products and services of the highest standard. Our group covers four essential and rapidly evolving areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and MedTech. Vimian provides individual businesses with access to our networks, expertise, infrastructure and capital to accelerate innovation and growth. We are as passionate about supporting leadership within our existing businesses, as we are about welcoming new partners to the Vimian family – together helping us make an even greater impact by improving animal health. Headquartered in Stockholm, Sweden, Vimian and our family of companies reach over 15,000 customers in +150 markets, employ more than 700 people and have a combined annual turnover of approximately EUR 170 million. FNCA Sweden AB is appointed the Company’s Certified Adviser, info@fnca.se, +46 (0) 8-528 00 399. For more information, please visit: www.vimian.com.